Australia’s leading lure manufacturer, with a worldwide reputation of building tough, fish catching lures at a realistic price. Halco Tackle sells its products to over 70 countries and is the mainstay of many charter fleets and commercial fishermen because of their reliability and durability. Recreational anglers know the product as the one that works….
GWB Machine Tools Pty Ltd
GWB Machine Tools provides cutting, folding and processing solutions for manufacturers operating in Australia and New Zealand since 1990, with professional after-sales service and support that ensures your investment continues to produce year after year. GWB have decades of experience in the manufacturing and engineering business, meaning you receive expert service and support from people who understand your business. GWB Machine Tools is Australia’s sole distributor for LVD, Lissmac, MSS Nitrogen Generators, Remmert automation solutions and Kohler.
Guardhouse
Guardhouse is an end-to-end workforce management platform built specifically for the security industry. We help security companies streamline operations, boost compliance, and improve workforce efficiency. From intelligent scheduling and mobile patrol management to real-time reporting, invoicing, and payroll integrations, Guardhouse empowers firms to run smoother and scale faster. Trusted by over 500 customers globally, our cloud-based solution gives managers full visibility and control, while equipping guards with the tools they need on the ground. At GSX, we’re showcasing how Guardhouse is transforming security operations worldwide with smart, reliable, and scalable software.
Grub Lab
Revolutionize the dining experience with GrubLab! Our interactive, gamified menus turn every visit into an unforgettable adventure keeping young diners entertained, boosting guest satisfaction, and driving repeat business. Elevate engagement, and set your restaurant apart with the future of dining technology for little ones!
Green Energy & Carbon Management
Green Energy & Carbon Management are here to guide you through your new climate-related emissions disclosure responsibilities with deep engineering knowledge and passion. Have an expert by your side to audit your direct and indirect emissions and clearly understand your corporate obligations. Explore tailored strategies to invest in on-site energy efficiency, productivity improvements, and renewable generation opportunities and ultimately reduce energy and carbon costs in your business.
Gravotech Australia
Gravotech is the world leader in permanent marking & identification solutions using Lasers, dot peen and rotary engraving machines. With the cutting-edge technologies that we master for permanent marking and engraving. We are constantly exploring new solutions to innovate and shape the future of the Expression of Things. Laser, mechanical engraving, scribing & dot peen: we are the only ones to pioneer and master all these types of marking.
Government of NSW, Australia
With Australia’s largest population, strongest economy, and innovative life sciences sector, New South Wales (NSW) is home to an integrated, world-class health and medical research sector that is solving some of the world’s most complex and burdensome healthcare challenges. NSW has Australia’s largest and best-performing public healthcare system, and a globally significant research and development ecosystem with strong government backing. World-leading public healthcare is delivered through 228 public hospitals that are managed by 15 local health districts and two specialty networks, all supported by centralised policy and support pillars. The NSW Government has invested A$10.8 billion over four years for research and development. Continuous financial investment ensures that internationally recognised research is translated into therapies and practice both locally and globally. NSW is a premier destination for high-quality, efficient, and cost-effective clinical trials, particularly in early-phase. Trials in NSW are 28 percent less expensive than in the US, increasing to up to 60 percent with federal R&D tax incentives.
Government of South Australia
South Australia South Australia is characterised by deep clinical research, manufacturing and an end-to-end clinical trial value chain supported by world-class infrastructure and digital capabilities. South Australia: Connected Innovation South Australia is characterised by deep clinical research, manufacturing and an end-to-end clinical trial value chain supported by world-class infrastructure and digital capabilities. It is a superbly collaborative and connected ecosystem for drug development, advanced manufacturing and health innovation. End-to-end clinical trial capabilities Australia’s unique regulatory framework means rapid start-up time without compromises. South Australia’s complete ecosystem is your most strategic entry point for exploring the whole Australian clinical trials sector, clustering end to end advice and expertise which provides the most efficient pathway to your clinical trial conduct. The state’s major hospitals each have world-class infrastructure with dedicated clinical trial units allowing access to dedicated investigators leading clinical research. South Australia is an ideal location for both healthy individuals and patients, including specialised patient populations. Fast and trusted for global markets (including FDA, EMA, TGA), working in South Australia will help you start your clinical trials in as little as six weeks. Data-driven precision health innovation Adelaide is home to world-leading artificial intelligence and data analytics capabilities, supported by unique clinical infrastructure and longitudinal datasets and biospecimen for cutting-edge clinical research and drug development. The Australian Institute for Machine Learning (AIML) has top globally ranked capability in artificial intelligence, machine learning, computer vision research and deep learning. AIML works with leading global companies including Roche, GSK and Medtronic to push the frontier of precision health. Manufacturing capability Australia’s commercial drug manufacturing pedigree was forged in South Australia and features many of its leading academic manufacturing resources and long-established commercial operations. Our contract development manufacturing organisations (CDMOs) support process development through to the cGMP clinical and commercial scale manufacturing to global regulations, with capability and breadth across small and large molecules. Adelaide is home to global operations for pharma and nutraceutical therapeutics, generics and supplement manufacturers. Drug development and biotech South Australia is a centre for drug research and new biotech companies. Key opinion leaders focus on drug development across a wide range of specialisations including immunology, infectious diseases, neuroscience and endocrinology. Oncology is a major focus, including precision health, Car-T technology, computational systems, epigenetics, single cell and spatial technologies, gene regulation, molecular signalling, translational oncology and cancer genomics. Connected innovation precincts Adelaide’s flagship precincts bring together worldclass researchers, companies, government, academia, infrastructure, investment, teaching and clinical care to create unique opportunities for innovation that underpin the state’s leadership and strengths in health and medical sectors. These include Adelaide BioMed City, Tonsley and Lot Fourteen Innovation Districts, ensuring health and life science research, manufacturing and clinical care are embedded with technology innovation. This makes Adelaide and South Australia the perfect location to collaborate, innovate, and trial new products, ready for global commercialisation. The Department of State Development facilitate: • Companies contemplating expansion to Australia and/or the Asia Pacific region via Australia. • Companies and investors looking for investment opportunities. • Companies who are interested in connecting with South Australian companies for services, products and/or collaboration.